The prognostic impact of subclonal IDH1 mutation in grade 2–4 astrocytomas

BACKGROUND: Isocitrate dehydrogenase (IDH) mutations are thought to represent an early oncogenic event in glioma evolution, found with high penetrance across tumor cells; however, in rare cases, IDH mutation may exist only in a small subset of the total tumor cells (subclonal IDH mutation). METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Vij, Meenakshi, Yokoda, Raquel T, Rashidipour, Omid, Tran, Ivy, Vasudevaraja, Varshini, Snuderl, Matija, Yong, Raymund L, Cobb, William S, Umphlett, Melissa, Walker, Jamie M, Tsankova, Nadejda M, Richardson, Timothy E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263115/
https://www.ncbi.nlm.nih.gov/pubmed/37324217
http://dx.doi.org/10.1093/noajnl/vdad069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263115/
https://www.ncbi.nlm.nih.gov/pubmed/37324217
http://dx.doi.org/10.1093/noajnl/vdad069

Ejemplares similares